TRISHA COCKRELL: Open Payments
NPI 1073971909 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 59 payments from 21 companies in 2025. Trend: 2023 $1,797 · 2024 $1,871 · 2025 $1,261
Food & beverage: $1,261
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $292 |
| AstraZeneca Pharmaceuticals LP | 9 | $149 |
| PFIZER INC. | 5 | $119 |
| GlaxoSmithKline, LLC. | 5 | $108 |
| Merck Sharp & Dohme LLC | 5 | $93 |
| Janssen Biotech, Inc. | 4 | $76 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Karyopharm Therapeutics Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Stemline Therapeutics Inc. | 2 | $32 |
Products named: ENHERTU, EPKINLY, KEYTRUDA, IBRANCE, IMBRUVICA, OJJAARA, VENCLEXTA, XPOVIO.
Industry payments across MO — which companies pay providers there.
